SELECTA BIOSCIENCES
Startup
SELECTA BIOSCIENCES
Description
Selecta Biosciences develops ImmTOR immune tolerance platform designed for a range of biologic therapies for rare and serious diseases that require new treatment options due to high immunogenicity.
Resources
SELECTA BIOSCIENCES
Address
United States
Contact
info@selectabio.com
Description
Selecta Biosciences develops ImmTOR immune tolerance platform designed for a range of biologic therapies for rare and serious diseases that require new treatment options due to high immunogenicity.
Resources
Matchmaking
Connect with SELECTA BIOSCIENCES
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways